Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Noel

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|October 5, 2020
Does early chimerism testing predict outcomes after allogeneic hematopoietic stem cell transplantation?Luke Mountjoy, Jeanne Palmer, Katie L Kunze, et al.
Blood|September 16, 2004
A sustained and pancellular reversal of gamma-globin gene silencing in adult human erythroid precursor cellsNatarajan V Bhanu, Tiffany A Trice, Y Terry Lee, et al.
Biochimica Et Biophysica Acta|July 1, 2008
Inhibition of erythroblast growth and fetal hemoglobin production by ribofuranose-substituted adenosine derivativesNatarajan V Bhanu, Y Terry Lee, Patricia A Oneal, et al.
BMC Pharmacology & Toxicology|August 14, 2013
Memory loss during lenalidomide treatment: a report on two casesAdeline Rollin-Sillaire, Xavier Delbeuck, Marianne Pollet, et al.
Blood|January 29, 2011
KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferationYoul-Nam Lee, Stephanie Brandal, Pierre Noel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2014
Financial burden in recipients of allogeneic hematopoietic cell transplantationNandita Khera, Yu-hui Chang, Shahrukh Hashmi, et al.
Leukemia & Lymphoma|April 14, 2020
Clinical outcomes with low dose anti-thymocyte globulin in patients undergoing matched unrelated donor allogeneic hematopoietic cell transplantationLuke Mountjoy, Tania Jain, Katie L Kunze, et al.
Leukemia & Lymphoma|July 12, 2014
Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantationNandita Khera, Yu-Hui Chang, James Slack, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2013
Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatchJames L Slack, Amylou C Dueck, Veena D Fauble, et al.
Mayo Clinic Proceedings. Digital Health|April 10, 2025
Satellite-Linked Remote Physiologic Monitoring During Simulated Rural Ground Ambulance and Rotor Wing TransportsChristopher S Russi, Christopher Felton, Chad Liedl, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|October 5, 2020
Does early chimerism testing predict outcomes after allogeneic hematopoietic stem cell transplantation?Luke Mountjoy, Jeanne Palmer, Katie L Kunze, et al.
Blood|September 16, 2004
A sustained and pancellular reversal of gamma-globin gene silencing in adult human erythroid precursor cellsNatarajan V Bhanu, Tiffany A Trice, Y Terry Lee, et al.
Biochimica Et Biophysica Acta|July 1, 2008
Inhibition of erythroblast growth and fetal hemoglobin production by ribofuranose-substituted adenosine derivativesNatarajan V Bhanu, Y Terry Lee, Patricia A Oneal, et al.
BMC Pharmacology & Toxicology|August 14, 2013
Memory loss during lenalidomide treatment: a report on two casesAdeline Rollin-Sillaire, Xavier Delbeuck, Marianne Pollet, et al.
Blood|January 29, 2011
KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferationYoul-Nam Lee, Stephanie Brandal, Pierre Noel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2014
Financial burden in recipients of allogeneic hematopoietic cell transplantationNandita Khera, Yu-hui Chang, Shahrukh Hashmi, et al.
Leukemia & Lymphoma|April 14, 2020
Clinical outcomes with low dose anti-thymocyte globulin in patients undergoing matched unrelated donor allogeneic hematopoietic cell transplantationLuke Mountjoy, Tania Jain, Katie L Kunze, et al.
Leukemia & Lymphoma|July 12, 2014
Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantationNandita Khera, Yu-Hui Chang, James Slack, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2013
Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatchJames L Slack, Amylou C Dueck, Veena D Fauble, et al.
Mayo Clinic Proceedings. Digital Health|April 10, 2025
Satellite-Linked Remote Physiologic Monitoring During Simulated Rural Ground Ambulance and Rotor Wing TransportsChristopher S Russi, Christopher Felton, Chad Liedl, et al.
Pageof 7